Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Ophthalmic Suspension
.
Show all posts
Showing posts with label
Ophthalmic Suspension
.
Show all posts
Friday, January 22, 2021
FDA Approves Eysuvis (loteprednol etabonate) Ophthalmic Suspension for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease
›
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovat...
›
Home
View web version
